Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs

Veterinary Immunology and Immunopathology

Volumn 151, Issue 1-2, 2013, Pages 132-139

  Shin, Min Kyoung ^a   Kang, Mi Lan ^a   Jung, Myung Hwan ^a   Cha, Seung Bin ^a   Lee, Won Jung ^a   Kim, Jung Mi ^b   Kim, Dae Hyuk ^b   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Actinobacillus pleuropneumoniae; ApxIA; ApxIIA; Oral immunization; Pig; Saccharomyces cerevisiae

Indexed keywords

APXIA TOXIN; APXIIA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SACCHAROMYCES CEREVISIAE PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PORCINE PLEUROPNEUMONIA; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; SWINE; VIRULENCE;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL VACCINES; BASE SEQUENCE; DNA, BACTERIAL; FEMALE; HEMOLYSIN PROTEINS; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLEUROPNEUMONIA, CONTAGIOUS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SUS SCROFA; SWINE; SWINE DISEASES; VACCINATION; VACCINES, SYNTHETIC;

ACTINOBACILLUS PLEUROPNEUMONIAE; MURINAE; MUS; MYCOPLASMA; SACCHAROMYCES CEREVISIAE; SUIDAE; SUS;

EID: 84871677714     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.11.003     Document Type: Article

References (33)

1. Beier R., Gebert A. Kinetics of particle uptake in the domes of Peyer's patches. Am. J. Physiol. 1998, 275:G130-G137.
2. Boekema B.K., Kamp E.M., Smits M.A., Smith H.E., Stockhofe-Zurwieden N. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence. Vet. Microbiol. 2004, 100:17-23.
3. Bosse J.T., Janson H., Sheehan B.J., Beddek A.J., Rycroft A.N., Kroll J.S., Langford P.R. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect. 2002, 4:225-235.
4. Buettner F.F., Bendallah I.M., Bosse J.T., Dreckmann K., Nash J.H., Langford P.R., Gerlach G.F. Analysis of the Actinobacillus pleuropneumoniae ArcA regulon identifies fumarate reductase as a determinant of virulence. Infect. Immun. 2008, 76:2284-2295.
5. Challacombe S.J. Assessing mucosal humoral immunity. Clin. Exp. Immunol. 1995, 100:181-182.
6. Cruijsen T.L., Van Leengoed L.A., Dekker-Nooren T.C., Schoevers E.J., Verheijden J.H. Phagocytosis and killing of Actinobacillus pleuropneumoniae by alveolar macrophages and polymorphonuclear leukocytes isolated from pigs. Infect. Immun. 1992, 60:4867-4871.
7. Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol. 1995, 3:257-261.
8. Frey J., Nicolet J. Immunological properties of Actinobacillus pleuropneumoniae hemolysin I. Vet. Microbiol. 1991, 28:61-73.
9. Frey J., Van Den Bosch H., Segers R., Nicolet J. Identification of a second hemolysin (HlyII) in Actinobacillus pleuropneumoniae serotype 1 and expression of the gene in Escherichia coli. Infect. Immun. 1992, 60:1671-1676.
10. Haesebrouck F., Chiers K., Van Overbeke I., Ducatelle R. Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet. Microbiol. 1997, 58:239-249.
11. Hannan P.C., Bhogal B.S., Fish J.P. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res. Vet. Sci. 1982, 33:76-88.
12. Hensel A., Stockhofe-Zurwieden N., Petzoldt K., Lubitz W. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge. Infect. Immun. 1995, 63:3048-3053.
13. Kim J.M., Jung D.I., Eom Y.J., Park S.M., Yoo H.S., Jang Y.S., Yang M.S., Kim D.H. Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae. Biosci. Biotechnol. Biochem. 2010, 74:1362-1367.
14. Krejci J., Nechvatalova K., Kudlackova H., Faldyna M., Kucerova Z., Toman M. Systemic and local antibody responses after experimental infection with Actinobacillus pleuropneumoniae in piglets with passive or active immunity. J. Vet. Med. B. 2005, 52:190-196.
15. Kweon M.N. Sublingual mucosa: a new vaccination route for systemic and mucosal immunity. Cytokine 2011, 54:1-5.
16. Lee K.Y., Kim D.H., Kang T.J., Kim J., Chung G.H., Yoo H.S., Arntzen C.J., Yang M.S., Jang Y.S. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol. Med. Microbiol. 2006, 48:381-389.
17. Maas A., Jacobsen I.D., Meens J., Gerlach G.F. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals. Infect. Immun. 2006, 74:4124-4132.
18. Marois C., Gottschalk M., Morvan H., Fablet C., Madec F., Kobisch M. Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae. Vet. Microbiol. 2009, 135:283-291.
19. Rayamajhi N., Shin S.J., Kang S.G., Lee D.Y., Ahn J.M., Yoo H.S. Development and use of a multiplex polymerase chain reaction assay based on Apx toxin genes for genotyping of Actinobacillus pleuropneumoniae isolates. J. Vet. Diagn. Invest. 2005, 17:359-362.
20. Reimer D., Frey J., Jansen R., Veit H.P., Inzana T.J. Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5. Microb. Pathogenesis 1995, 18:197-209.
21. Sadilkova L., Nepereny J., Vrzal V., Sebo P., Osicka R. Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia. Vet. Res. 2012, 43:2.
22. Schreuder M.P., Deen C., Boersma W.J., Pouwels P.H., Klis F.M. Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine 1996, 14:383-388.
23. Seo K.W., Kim D.H., Kim A.H., Yoo H.S., Lee K.Y., Jang Y.S. Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge. Immunol. Invest. 2011, 40:465-480.
24. Shams H. Recent developments in veterinary vaccinology. J. Vet. 2005, 170:289-299.
25. Shin M.K., Kang M.L., Cha S.B., Lee W.J., Sung J.H., Yoo H.S. An immunosorbent assay based on the recombinant ApxIA ApxIIA, and ApxIIIA toxins of Actinobacillus pleuropneumoniae and its application to field sera. J. Vet. Diagn. Invest. 2011, 23:736-742.
26. Shin S.J., Bae J.L., Cho Y.W., Lee D.Y., Kim D.H., Yang M.S., Jang Y.S., Yoo H.S. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA. FEMS Immunol. Med. Microbiol. 2005, 43:155-164.
27. Shin S.J., Bae J.L., Cho Y.W., Yang M.S., Kim D.H., Jang Y.S., Yoo H.S. Expression of apxIA of Actinobacillus pleuropneumoniae in Saccharomyces cerevisiae. J. Vet. Sci. 2003, 4:225-228.
28. Shin S.J., Shin S.W., Kang M.L., Lee D.Y., Yang M.S., Jang Y.S., Yoo H.S. Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice. J. Vet. Sci. 2007, 8:383-392.
29. Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., Franzusoff A., Duke R.C., Wilson C.C. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat. Med. 2001, 7:625-629.
30. Tascon R.I., Vazquez-Boland J.A., Gutierrez-Martin C.B., Rodriguez-Barbosa I., Rodriguez-Ferri E.F. The RTX haemolysins ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis. Mol. Microbiol. 1994, 14:207-216.
31. Ueda M., Tanaka A. Cell surface engineering of yeast: construction of arming yeast with biocatalyst. J. Biosci. Bioeng. 2000, 90:125-136.
32. van Ginkel F.W., Jackson R.J., Yuki Y., McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 2000, 165:4778-4782.
33. Zhang Y.M., Tennent J.M., Ingham A., Beddome G., Prideaux C., Michalski W.P. Identification of type 4 fimbriae in Actinobacillus pleuropneumoniae. FEMS Microbiol. Lett. 2000, 189:15-18.